open source digital currency Top Top stories

The Nikkei 225 index closed up 1.21% at 39,849.14.Zhongjing Technology: Changzhou Jinhong, a shareholder, intends to reduce its shareholding by no more than 3%. Zhongjing Technology announced that Changzhou Jinhong Enterprise Management Partnership (Limited Partnership), a shareholder holding more than 5%, intends to reduce its shareholding in the company by means of centralized bidding and block trading, with the reduction amount not exceeding 18,886,100 shares, that is, not exceeding 3% of the company's total share capital. The reduction price will be determined according to the market price when the reduction is implemented. This reduction will be carried out within three months after 15 trading days from the date of disclosure of this announcement.The European Central Bank opened the door for further interest rate cuts. On Thursday, the European Central Bank cut interest rates for the fourth time this year and opened the door for further interest rate cuts in the future, because inflation is close to its target and the economy is still weak. The European Central Bank lowered the deposit interest rate from 3.25% to 3.0%, and cancelled the statement that the interest rate remained "sufficiently restrictive", suggesting that it was possible to cut interest rates further. The European Central Bank said: "The financial environment is easing, because the recent interest rate cuts by the European Central Bank have gradually reduced the new borrowing costs of enterprises and households." "But the financial environment is still very tight, because monetary policy is still restrictive, and past interest rate hikes are still being transmitted to outstanding stock credit."

The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).Zhongding Co., Ltd. established a subsidiary of Robotics Technology. Tianyancha APP shows that Anhui Ruisibo Robotics Technology Co., Ltd. was recently established, with Xia Yingsong as its legal representative and a registered capital of 50 million yuan. Its business scope includes: research and development of intelligent robots; Intelligent robot sales; Industrial robot manufacturing; Industrial robot sales and so on. Tianyancha's equity penetration shows that the company is wholly owned by Zhongding.

During the "slimming" of the brokerage business department, more than 100 companies were cancelled during the year, and the competition turned to differentiated services. The brokerage business of brokerage companies is welcoming a new round of changes. In the past few days, a number of brokers have announced the cancellation of their relevant business departments. According to the reporter's incomplete statistics, in the past two weeks, many brokers such as Nanjing Securities, Guosen Securities and Pacific Securities announced that they would "streamline" their business departments. Looking at it for a long time, more than 35 brokers have issued announcements during the year, "downsizing" hundreds of business departments. Insiders pointed out that the traditional offline outlet business development model has increasingly shown drawbacks and high cost pressure; At the same time, more and more customers rely on online transactions and mobile terminal transactions, so it is imperative to "streamline" the business department to reduce costs and increase efficiency. Future competition depends more on differentiated financial management and trading services. (Shell Finance)Reuters survey: Most economists believe that the tariff proposed by US President-elect Trump has little impact on the British economy; It is estimated that the Bank of England will cut interest rates by 100 basis points in 2025, and may cut interest rates by 25 basis points every quarter; A survey of 71 interviewed economists shows that the Bank of England's interest rate is expected to remain unchanged at 4.75% on December 19th.The turnover of Shanghai and Shenzhen stock markets exceeded 1.5 trillion yuan for the fifth consecutive trading day.